← Open Payments lookup

DAVID ANAKWENZE: Open Payments

NPI 1356306559 · FLORENCE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,689 in 66 payments from 12 companies in 2025. Trend: 2023 $1,308 · 2024 $1,848 · 2025 $1,689

Food & beverage: $1,579Education: $109
CompanyPaymentsAmount
Alkermes, Inc.22$555
Vanda Pharmaceuticals Inc.8$219
Teva Pharmaceuticals USA, Inc.5$209
Neurocrine BioSciences, Inc.8$182
Otsuka America Pharmaceutical, Inc.3$150
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$146
E.R. Squibb & Sons, L.L.C.4$89
Almatica Pharma LLC2$45
Axsome Therapeutics, Inc.2$36
Janssen Pharmaceuticals, Inc2$31

Products named: ARISTADA, FANAPT, INGREZZA, CAPLYTA, LYBALVI, REXULTI, COBENFY, AUSTEDO XR.

Industry payments across AL — which companies pay providers there.